Instruction for use: Salbutamol-Teva

Active substance Salbutamol

ATX Code R03CC02 Salbutamol

Pharmacotherapeutic group:

Bronchodilator agent - a selective beta2-agonists [beta-adrenergic agonist]

The nosological classification (ICD-10)

J42 Chronic bronchitis, unspecified

recurrent bronchitis, Bronchitis asthma, wheeze bronchitis, chronic Bronchitis, Inflammatory airways disease, bronchi disease, Qatar smoker, Cough in inflammatory diseases of the lung and bronchus, Exacerbation of Chronic Bronchitis, Chronic bronchitis, Chronic obstructive pulmonary disease, Chronical bronchitis, Chronic bronchitis smokers, Chronic spastic bronchitis, allergic Bronchitis

J43 Emphysema

Interstitial emphysema, Emphysema, Chronic lung disease, Chronic obstructive pulmonary disease, Obstructive pulmonary emphysema, Chronic pulmonary emphysema, Chronic obstructive pulmonary emphysema

J44.9 Chronic obstructive pulmonary disease, unspecified

Obstructive pulmonary diseases, Bronchial obstruction, bronchial obstruction, Exacerbation of chronic obstructive pulmonary disease, reversible airflow obstruction, Reversible airway obstruction, panbronchiolitis, Panbronhit, COPD, Chronic pulmonary infection, Chronic infection of the lower respiratory tract, Chronic obstructive pulmonary disease, Chronic obstructive pneumonia, Chronic lung disease, Chronic obstructive pulmonary disease, Chronic bronchopulmonary disease, Chronic broncho-pulmonary diseases, Airway obstruction

J45 Asthma

Asthma physical effort, status asthmaticus, Bronchial asthma, Asthma lung flow, Bronchial asthma with obstruction of sputum discharge, Bronchial asthma heavy currents, Bronchial asthma physical effort, hypersecretory asthma, Hormone-dependent form of bronchial asthma, Relief of asthma attacks in bronchial asthma, Non-allergic asthma, nocturnal asthma, Exacerbation of asthma, Asthma attacks, Endogenous forms of asthma, Night asthma, Cough with bronchial asthma

J98.8.0 * Bronchospasm

Bronchospasm in bronchial asthma, Bronchospasm when exposed to an allergen, bronchospastic reactions, bronchospastic status, bronhospastichesky syndrome, Diseases accompanied by bronchospastic syndrome, reversible bronchospasm, spasmodic cough

Structure and Composition

Aerosol for inhalation dose 1 dose

active substance:

salbutamol sulphate 124 mg

(Equivalent to 100 mcg salbutamol)

Excipients: hydrofluoroalkane (HFA-134a) - 26,46 mg; Ethanol - 3.42 mg

pharmachologic effect

bronchodilator.

Dosing and Administration

Inhalation.

For relief of bronchospasm: 100 g (1 inhalation) 1-4 times a day. If necessary, the dose may be increased up to 200 micrograms (2 inhalation) 1-4 times a day.

For the prevention of bronchospasm: 100-200 g (1-2 inhalation) for 15-30 minutes before exercise or exposure to a possible allergen.

The maximum daily dose should not exceed 800 mcg (8 inhalations) during the day.

Between each received a dose should be at least 4 hours.

Instructions for the patient on the use of the inhalation device

Before the first use of the inhalation device, or if it is some time not been used, you need to check it is working properly by pressing the spray valve and releasing a dose of medicine into the air.

1. Remove the inhalation device with protective cap and ensure that the output tube inhalation device clean. Hold the inhalation device between the index finger and thumb in a vertical position, with the thumb should be placed on the bottom of the inhalation device, and the index - on the metering valve aluminum cylinder.

2. Intensively shake the aluminum bottle up and down.

3. Take a deep breath through your mouth. Firmly pinch the lips outlet pipe of the inhalation device.

4. Make a slow, deep breath. The inspiratory time of the index finger to press on the dosing cylinder valve, releasing a dose of the drug Salbutamol-Teva, continue to slowly inhale.

5. Remove the inhalation device from the mouth and hold your breath for 10 seconds or at a time that does not cause discomfort. Slowly exhale.

6. After inhalation, rinse your mouth with water, being careful not to swallow the spray, which fell during inhalation on oral mucosa.

7. If you want to enter more than one dose, wait 1 minute and repeat the procedure from step 2, and the last step 6.

8. Close the inhalation device protective cap.

In steps 3 and 4 should not be rushed. At the time of release dose medication is important to breathe in as slowly as possible. Before applying, you can practice in the mirror. If you have seen "steam" coming from the top of a container or out of the corners of the mouth, it is necessary to start again from step 2.

Shoe inhaler. The inhalation device should be cleaned at least 1 time per week. Remove the aluminum cylinder of the inhalation device. Carefully rinse the inhalation device and a protective cap with warm water. Do not use hot water! Shake the inhalation device and a protective cap to remove the remaining water and dry them without the use of heating devices.

We can not allow the aluminum cylinder into contact with water!

release Form

Aerosol for inhalation dose, 100 ug / dose. At doses of 200 aluminum cylinder with a dosing valve, with the inhalation device fitted with a protective cap; 1 point. in a cardboard bundle.

Storage conditions of the drug Salbutamol-Teva

In sheltered from direct sunlight, at a temperature no higher than 25 ° C. Do not freeze.

Keep out of the reach of children.

The shelf life of the drug Salbutamol-Teva

3 years.

Do not use beyond the expiration date printed on the package.

On prescription.